# Required Extraction Fields Strategy
**Date**: 2025-11-01
**Purpose**: Define required fields for MedGemma binary extraction across all treatment modalities
**Status**: Surgery/Radiation/Imaging IMPLEMENTED | Chemotherapy PLANNED

---

## Executive Summary

This document defines the **required fields** that must be extracted from clinical documents for each gap type in the Patient Clinical Journey Timeline Framework. These fields drive the **escalating search strategy** where Agent 1 (Claude) validates that Agent 2 (MedGemma) successfully extracts ALL required fields before marking an extraction as complete.

**Key Principle**: If required fields are missing after primary document extraction + re-extraction, the system **automatically escalates to alternative documents** (progress notes, discharge summaries, etc.) until all fields are found or alternatives are exhausted.

---

## Implementation Status

| Treatment Modality | Phase 3 (Gap ID) | Phase 4 (Extraction) | Phase 5 (Validation) | Status |
|-------------------|------------------|---------------------|---------------------|---------|
| **Surgery (EOR)** | ‚úÖ Implemented | ‚úÖ Implemented | ‚úÖ Implemented | **ACTIVE** |
| **Radiation** | ‚úÖ Implemented | ‚úÖ Implemented | ‚úÖ Implemented | **ACTIVE** |
| **Imaging (RANO)** | ‚úÖ Implemented | ‚úÖ Implemented | ‚ö†Ô∏è Partial | **ACTIVE** |
| **Chemotherapy** | ‚ùå Not Implemented | ‚ùå Not Implemented | ‚ùå Not Implemented | **PLANNED** |

---

## 1. Surgery: Extent of Resection (EOR)

### Gap Type: `missing_eor`

### Required Fields (2)

| Field Name | Data Type | Description | Example Values | Validation Source |
|------------|-----------|-------------|----------------|-------------------|
| **extent_of_resection** | string | Categorical resection extent | "gross_total_resection", "subtotal_resection", "biopsy_only" | Operative note + Post-op MRI |
| **surgeon_assessment** | string | Verbatim surgeon's assessment | "Complete gross total resection of right frontal mass achieved" | Operative note procedure description |

### Clinical Rationale

**Dual-source validation required**:
- **Operative notes**: Surgeon's intraoperative assessment (subjective)
- **Post-operative imaging** (MRI within 72 hours): Radiographic confirmation of resection extent (objective)

**Why both sources matter**:
- Surgeon may report "gross total resection" but post-op MRI shows residual enhancement
- Standard of care includes early post-op MRI (within 24-72 hours) for neuro-oncology patients
- Objective imaging provides ground truth for residual disease measurement

### Escalation Strategy

**Primary target**: Operative note binary
**Alternative documents** (in priority order):
1. Post-operative imaging reports (MRI within ¬±7 days)
2. Discharge summaries (contain operative summary + imaging results)
3. Consultation notes (post-op follow-up)

### Implementation Status: ‚úÖ IMPLEMENTED
- **Location**: `patient_timeline_abstraction_V2.py:1875`
- **Guidance updated**: Lines 1913 (includes post-op imaging reference)

---

## 2. Radiation: Treatment Episode Details

### Gap Type: `missing_radiation_details`

### Required Fields (4)

| Field Name | Data Type | Description | Example Values | Clinical Significance |
|------------|-----------|-------------|----------------|----------------------|
| **date_at_radiation_start** | date (YYYY-MM-DD) | First day of radiation treatment | "2023-04-15" | Episode start boundary |
| **date_at_radiation_stop** | date (YYYY-MM-DD) | Last day of radiation treatment | "2023-06-08" | Episode end boundary - CRITICAL for re-irradiation tracking |
| **total_dose_cgy** | integer | Total cumulative dose in centiGray | 5400 (= 54 Gy) | Dosimetry validation |
| **radiation_type** | string (enum) | Anatomical treatment pattern | "focal", "craniospinal", "whole_ventricular", "focal_with_boost" | Protocol compliance |

### Clinical Rationale

**Why `date_at_radiation_stop` is REQUIRED**:
- Track **re-irradiation episodes** upon progression/recurrence
- Distinguish **multiple treatment courses** (initial vs. salvage radiation)
- Calculate **treatment duration** (days from start to stop)
- Identify **concurrent vs. sequential** treatment patterns

**Re-irradiation example**:
- Patient receives 54 Gy focal radiation (2018-04-15 to 2018-06-08)
- Disease progresses in 2020
- Patient receives salvage radiation 30 Gy (2020-09-01 to 2020-10-15)
- **Without end dates**, these episodes cannot be distinguished

### Validation Keywords (Comprehensive)

From SQL-aligned radiation terminology (`patient_timeline_abstraction_V2.py:1818-1836`):

**Core radiation terms**: radiation, radiotherapy, radiosurgery, xrt, rt, imrt
**Treatment modalities**: proton, cyberknife, gamma knife, sbrt, srs
**Anatomical patterns**: craniospinal, csi, focal, whole brain, wbrt, ventricular, spine, boost, local, field
**Dose & delivery**: dose, gy, cgy, gray, dosage, fraction, fractions, fractionation, beam, beams, port, fields
**Planning terms**: treatment, therapy, plan, planning, simulation, sim, delivery, tx, rx

**Minimum keywords required**: 2 (lowered from 3 to increase sensitivity)

### Escalation Strategy

**Primary target**: Radiation-specific documents (treatment summaries, planning notes)
**Alternative documents** (temporal + type prioritization):
1. **Radiation documents** (¬±30 days, highest priority)
2. **Progress notes** (¬±30 days, mentions of treatment dates/doses)
3. **Discharge summaries** (¬±60 days, comprehensive treatment summaries)
4. **Treatment plans** (¬±90 days, planning documentation)

**No keyword filtering on alternatives** - rely on temporal proximity + document type + MedGemma validation


---

## 3. Imaging: RANO Response Assessment

### Required Fields (2)

| Field Name | Data Type | Description | Example Values | Clinical Use |
|------------|-----------|-------------|----------------|--------------|
| **lesions** | array of objects | Tumor lesions with measurements | `[{"location": "right frontal", "size_mm": 32, "enhancement": true}]` | Tumor burden tracking |
| **rano_assessment** | string (enum) | RANO criteria response | "complete_response", "partial_response", "stable_disease", "progressive_disease" | Treatment efficacy |

### Clinical Rationale

**RANO (Response Assessment in Neuro-Oncology)** criteria:
- Standardized measurement of brain tumor response to treatment
- Combines lesion size changes, new lesions, clinical status, and steroid use
- Required for clinical trial reporting and treatment decision-making

### Escalation Strategy

**Primary target**: Diagnostic report from imaging event
**Alternative documents**:
1. Subsequent imaging reports (compare serial scans)
2. Oncology progress notes (contain imaging interpretation)
3. Tumor board summaries (comprehensive assessment)

### Implementation Status: ‚úÖ IMPLEMENTED
- **Location**: `patient_timeline_abstraction_V2.py:1882`
- **Validation**: Partial (RANO schema validation needs enhancement)

---

## 4. Chemotherapy: Protocol and Therapy Changes

### Gap Type: `missing_chemotherapy_details` (PLANNED)

### Required Fields (6)

| Field Name | Data Type | Description | Example Values | Clinical Significance |
|------------|-----------|-------------|----------------|----------------------|
| **protocol_name** | string | Name or number of clinical protocol | "COG ACNS0126", "SJMB12", "ACNS1422" | Protocol compliance tracking |
| **on_protocol_status** | string (enum) | Enrollment status | "enrolled", "treated_as_per_protocol", "treated_like_protocol", "off_protocol" | Distinguishes enrolled vs. protocol-guided care |
| **agent_names** | array of strings | Chemotherapy drug names | `["Temozolomide", "Vincristine", "Carboplatin"]` | Regimen identification |
| **start_date** | date (YYYY-MM-DD) | Treatment episode start | "2023-04-15" | Episode boundary |
| **end_date** | date (YYYY-MM-DD) | Treatment episode end | "2023-10-20" | Episode boundary |
| **change_in_therapy_reason** | string (nullable) | Reason for therapy modification | "progression", "toxicity", "patient_preference", null | Treatment trajectory analysis |

### Clinical Rationale

**Protocol tracking importance**:
- Pediatric brain tumor patients often enrolled in multi-institutional protocols (COG, SJMB, ACNS)
- "Enrolled" vs. "treated as per protocol" distinction affects:
  - Data collection requirements
  - Follow-up schedules
  - Outcome reporting obligations
- Off-protocol modifications common due to toxicity or disease progression

**Change in therapy reasons**:
- **Progression**: Disease not responding, escalate treatment
- **Toxicity**: Dose reduction or agent substitution needed
- **Patient preference**: Family requests treatment modification
- **Protocol amendment**: Study design changes mid-treatment

**Episode tracking**:
- Multiple chemotherapy courses common (induction ‚Üí consolidation ‚Üí maintenance)
- Re-challenge with same agents after progression
- Start/end dates distinguish separate treatment episodes

### Validation Keywords (Proposed)

**Protocol terms**: protocol, trial, study, enrolled, enrollment, consent, COG, ACNS, SJMB, POG
**Chemotherapy terms**: chemotherapy, chemo, agent, drug, cycle, course, regimen, infusion
**Agent names**: temozolomide, vincristine, carboplatin, cisplatin, etoposide, cyclophosphamide, lomustine
**Change indicators**: changed, modified, discontinued, stopped, held, dose reduction, escalation, toxicity, progression



### Escalation Strategy (Proposed)

**Primary target**: Chemotherapy treatment summaries, infusion records
**Alternative documents**:
1. **Treatment plan documents** (protocol enrollment forms)
2. **Progress notes** (treatment discussions, dose modifications)
3. **Discharge summaries** (comprehensive treatment history)
4. **Consultation notes** (oncology visits discussing therapy changes)

### Document Source Priority

| Document Type | Priority | Typical Content | Days from Event |
|---------------|----------|-----------------|-----------------|
| Chemotherapy treatment summary | 1 (HIGHEST) | Complete protocol details, all agents, doses | ¬±7 days |
| Infusion records | 2 | Agent names, doses, dates | Same day |
| Oncology progress notes | 3 | Treatment discussions, toxicity, modifications | ¬±14 days |
| Discharge summaries | 4 | Comprehensive treatment history | ¬±30 days |
| Treatment plans | 5 | Protocol enrollment, consent forms | ¬±60 days |



**Blocked by**:
- Phase 3 gap identification logic not implemented
- Phase 4 extraction prompt not created
- Phase 5 WHO 2021 protocol validation not defined

**Estimated implementation**:
- Phase 3 (gap ID): 1-2 hours
- Phase 4 (extraction): 2-3 hours
- Phase 5 (validation): 1-2 hours
- Testing: 2-4 hours
- **Total**: 6-11 hours

---

## Implementation Strategy

### Current Session (2025-11-01)

**Phase 1**: ‚úÖ Test and validate current implementation (Surgery/Radiation/Imaging)
- Verify HTML content type fix working
- Confirm comprehensive radiation keywords detecting documents
- Validate escalation strategy proceeding through alternatives
- Test with multiple patients (Astrocytoma, Pineoblastoma)

**Phase 2**: üìã Document chemotherapy requirements (THIS DOCUMENT)

**Phase 3**: ‚è≥ Implement chemotherapy extraction (FUTURE)

### Recommended Implementation Order

1. **Validate current workflow** (Surgery/Radiation/Imaging) - **PRIORITY 1**
   - Run end-to-end tests with fixed HTML extraction
   - Verify escalation to alternatives working
   - Compare against human abstraction examples
   - Identify any remaining bugs or data quality issues

2. **Document chemotherapy requirements** - **PRIORITY 2** ‚úÖ COMPLETE
   - Define required fields (this document)
   - Align with WHO 2021 protocol expectations
   - Review with domain experts

3. **Implement chemotherapy extraction** - **PRIORITY 3** (FUTURE)
   - Phase 3: Gap identification logic
   - Phase 4: MedGemma extraction prompt
   - Phase 5: Protocol validation
   - Testing with diverse chemotherapy regimens

---

## Escalating Search Strategy (Overview)

### Two-Agent Validation Loop

```
PRIMARY DOCUMENT ATTEMPT
‚îÇ
‚îú‚îÄ Agent 1: Fetch document from primary target
‚îú‚îÄ Agent 1: VALIDATE content (keyword matching)
‚îú‚îÄ Agent 2 (MedGemma): Extract structured data
‚îú‚îÄ Agent 1: VALIDATE extraction (required fields check)
‚îÇ
‚îú‚îÄ If incomplete ‚Üí RE-EXTRACTION with clarification prompt
‚îÇ
‚îî‚îÄ Still incomplete ‚Üí ESCALATION TO ALTERNATIVES
    ‚îÇ
    ‚îú‚îÄ Alternative #1 (highest temporal proximity + document type priority)
    ‚îÇ   ‚îú‚îÄ Agent 1: VALIDATE content
    ‚îÇ   ‚îú‚îÄ Agent 2: Extract
    ‚îÇ   ‚îú‚îÄ Agent 1: VALIDATE result
    ‚îÇ   ‚îî‚îÄ If incomplete ‚Üí Continue
    ‚îÇ
    ‚îú‚îÄ Alternative #2
    ‚îú‚îÄ Alternative #3
    ‚îú‚îÄ Alternative #4
    ‚îú‚îÄ Alternative #5 (max limit)
    ‚îÇ
    ‚îî‚îÄ All exhausted ‚Üí Mark as UNAVAILABLE_IN_RECORDS
```

### Design Rationale

**Why this strategy is clinically sound**:
1. **Temporal proximity**: Documents near event dates likely contain relevant information
2. **Document type prioritization**: Treatment summaries > progress notes > discharge summaries
3. **Keyword validation**: Ensures document relevance before expensive LLM extraction
4. **Multiple attempts**: Clinical data often scattered across multiple documents
5. **Escalation limit**: Prevents infinite loops on truly missing data

**When it fails** (expected scenarios):
- Data never documented (e.g., outside institution radiation, verbal surgeon assessment only)
- Binary files corrupted or missing from S3
- Clinical notes use non-standard terminology (mitigated by comprehensive keyword lists)
- Information exists but in non-text format (images, scanned PDFs without OCR)

---

## Testing and Validation

### Test Patients

| Patient ID | WHO 2021 Diagnosis | Key Testing Focus |
|------------|-------------------|-------------------|
| `eQSB0y3q.OmvN40Yhg9.eCBk5-9c-Qp-FT3pBWoSGuL83` | Astrocytoma, IDH-mutant, Grade 3 | Radiation escalation, HTML extraction |
| `e8jPD8zawpt.KIpA97WuwdDCHyK.qEO5mX-6tEB7krPU3` | Pineoblastoma | Craniospinal+boost pattern, imaging RANO |

### Validation Criteria

**Successful extraction requires**:
1. ‚úÖ All required fields populated (no null values)
2. ‚úÖ Data clinically plausible (dates in valid range, doses in expected ranges)
3. ‚úÖ Matches human abstraction (when gold standard available)
4. ‚úÖ Extraction confidence HIGH or MEDIUM (LOW triggers manual review)

### Human Abstraction Comparison

**Gold standard**: `/Users/resnick/Downloads/example extraction.csv`
**Comparison fields**:
- Surgery dates and EOR classification
- Radiation start/stop dates and total doses
- Chemotherapy protocols and agents
- Imaging response assessments

---

## References

### Code Locations

**Required fields definition**: `patient_timeline_abstraction_V2.py:1874-1883`
**Validation keywords**: `patient_timeline_abstraction_V2.py:1817-1841`
**Escalation logic**: `patient_timeline_abstraction_V2.py:1031-1126`
**Field guidance**: `patient_timeline_abstraction_V2.py:1912-1921`

### Related Documentation

- `PHASE4_IMPLEMENTATION_SUMMARY.md` - Phase 4 architecture and workflow
- `MEDGEMMA_ORCHESTRATION_ARCHITECTURE.md` - Two-agent validation loop design
- `RADIATION_EPISODE_APPROACH.md` - Radiation terminology and episode detection
- `HUMAN_ABSTRACTION_EXAMPLES.md` - Gold standard comparison examples

---

## Change Log

| Date | Change | Author | Rationale |
|------|--------|--------|-----------|
| 2025-11-01 | Added `date_at_radiation_stop` to required fields | Session continuation | Track re-irradiation episodes |
| 2025-11-01 | Updated EOR guidance to include post-op imaging | Session continuation | Dual-source validation (operative note + MRI) |
| 2025-11-01 | Expanded radiation keywords from 6 to 35+ terms | Session continuation | Align with SQL terminology, increase sensitivity |
| 2025-11-01 | Documented chemotherapy required fields (not implemented) | Session continuation | Future implementation roadmap |
| 2025-11-01 | Fixed HTML content type mislabeling bug | Session continuation | Documents declared as text/html were routed to PDF extractor |

---

## Next Steps

### Immediate (This Session)
1. ‚úÖ Document chemotherapy requirements (COMPLETE - this document)
2. ‚è≥ **Run comprehensive test with fixed HTML extraction** (NEXT)
3. ‚è≥ Validate escalation strategy working end-to-end
4. ‚è≥ Compare results against human abstraction

### Future Sessions
1. Implement chemotherapy Phase 3 gap identification
2. Create chemotherapy MedGemma extraction prompt
3. Add chemotherapy WHO 2021 protocol validation
4. Test with diverse chemotherapy regimens (TMZ, multi-agent protocols)
5. Expand to additional tumor types (medulloblastoma, ependymoma, etc.)
